Laurence Vergely

Statistics

Publications

Citations

155

H-Index

Active since

2012

Affiliations

Centre Hospitalier Universitaire de Montpellier(Current)

Hôpital Arnaud de Villeneuve

Université de Montpellier

Inserm

Centre National de la Recherche Scientifique

Laurence Vergely is an author at Centre Hospitalier Universitaire de Montpellier specializing in medicine, anthracycline cardiotoxicity, and anthracycline-induced cardiotoxicity.

Publications per year

2012–2022

Publications

Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients

Nausicaa Malissen, Laurence Vergely, Marguerite Simon et al. · Journal of the American Academy of Dermatology · 2017 · 53 citations

Medicine, Dermatology, Dermatopathology +3

Visual Acuity Outcome and Predictive Factors after Bevacizumab for Central Retinal Vein Occlusion

Vincent Daïen, S. Navarre, Pierre Fesler et al. · European Journal of Ophthalmology · 2012 · 37 citations

Medicine, Ophthalmology, Vision Science +17

Screening for <i>in-vivo</i> regional contractile defaults to predict the delayed Doxorubicin Cardiotoxicity in Juvenile Rat

Nourdine Chakouri, Charlotte Farah, Stéfan Matecki et al. · Theranostics · 2020 · 28 citations · Full text

Medicine, Cardiology, Pharmacology +17

Use of speckle tracking echocardiography to detect late anthracycline-induced cardiotoxicity in childhood cancer: A prospective controlled cross-sectional study

Pascal Amédro, Marie Vincenti, Hamouda Abassi et al. · International Journal of Cardiology · 2022 · 23 citations · Full text

Medicine, Cardiology, Oncology +16

Adverse reactions related to brentuximab vedotin use: A real-life retrospective study

Béatrice Clarivet, Laure Vincent, Laurence Vergely et al. · Therapies · 2018 · 14 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +6

1–5 of 5